Download presentation
Presentation is loading. Please wait.
Published byAngelica Jennings Modified over 6 years ago
1
Afatinib-Induced Severe Interstitial Lung Disease Successfully Treated with High-Dose Corticosteroid Therapy: A Case Report Kazutaka Fujita, MD, Yuko Morishima, MD, Yuka Aida, MD, Yoshiya Tsunoda, MD, Norihito Hida, MD, Toshihiro Shiozawa, MD, Kensuke Nakazawa, MD, Ikuo Sekine, MD, Nobuyuki Hizawa, MD Journal of Thoracic Oncology Volume 12, Issue 2, Pages e11-e13 (February 2017) DOI: /j.jtho Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions
2
Figure 1 On admission, chest radiography and computed tomography showed a 55-mm mass in the right upper lobe with enlarged hilar and mediastinal lymph nodes (A and B), and brain T1-weighted contrast-enhanced magnetic resonance imaging demonstrated a 38-mm cystic lesion in the right occipital lobe (C). Journal of Thoracic Oncology , e11-e13DOI: ( /j.jtho ) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions
3
Figure 2 (A) Chest radiography showed significant regression of the primary tumor after 1 month of treatment with afatinib. (B–D) However, 57 days after the patient started taking the afatinib, chest radiography and computed tomography demonstrated extensive bilateral alveolar infiltrates, suggesting the presence of diffuse alveolar damage. (E–G) After the afatinib was stopped and high-dose steroids were administered, the interstitial lung infiltrates were remarkably improved. Journal of Thoracic Oncology , e11-e13DOI: ( /j.jtho ) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.